Status:
UNKNOWN
Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Retinovascular Disease
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
In this study we intend to evaluate and compare the outcomes of intravitreal avastin versus avastin and triamcinolone on improving the visual acuity and macular edema and late complications of CRVO li...
Detailed Description
Central retinal vein occlusion (CRVO) is a common retinal vascular disorder with potentially complications like reduced vision resulting from extensive intraretinal hemorrhage, retinal ischemia and pe...
Eligibility Criteria
Inclusion
- CRVO with duration less than 6 months
Exclusion
- vision less than 20/320 and vison more than 20/50
- history of galucoma and diabetic retinopathy
- previous laser or intravitreal treatment
- any media opacity that prevents funduscopy
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00370630
Start Date
August 1 2006
End Date
February 1 2007
Last Update
February 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siamak Moradian, MD
Tehran, Tehran Province, Iran, 16666